These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
624 related articles for article (PubMed ID: 18803947)
1. Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis. Ziegelmeier M; Bachmann A; Seeger J; Lossner U; Kratzsch J; Blüher M; Stumvoll M; Fasshauer M Metabolism; 2008 Oct; 57(10):1414-21. PubMed ID: 18803947 [TBL] [Abstract][Full Text] [Related]
2. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality. Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928 [TBL] [Abstract][Full Text] [Related]
3. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus. Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467 [TBL] [Abstract][Full Text] [Related]
4. Effect of smoking habit on circulating adipokines in diabetic and non-diabetic subjects. Al Mutairi SS; Mojiminiyi OA; Shihab-Eldeen AA; Al Sharafi A; Abdella N Ann Nutr Metab; 2008; 52(4):329-34. PubMed ID: 18714151 [TBL] [Abstract][Full Text] [Related]
5. Relationship between glomerular filtration rate and the adipokines adiponectin, resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function. Risch L; Saely C; Hoefle G; Rein P; Langer P; Gouya G; Marte T; Aczel S; Drexel H Clin Chim Acta; 2007 Feb; 376(1-2):108-13. PubMed ID: 16956602 [TBL] [Abstract][Full Text] [Related]
6. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index. Ruge T; Lockton JA; Renstrom F; Lystig T; Sukonina V; Svensson MK; Eriksson JW Metabolism; 2009 Jun; 58(6):860-6. PubMed ID: 19375766 [TBL] [Abstract][Full Text] [Related]
7. Adiponectin, resistin and leptin response to dietary intervention in diabetic nephropathy. Kozłowska L; Rydzewski A; Fiderkiewicz B; Wasińska-Krawczyk A; Grzechnik A; Rosołowska-Huszcz D J Ren Nutr; 2010 Jul; 20(4):255-62. PubMed ID: 20537918 [TBL] [Abstract][Full Text] [Related]
8. Serum levels of the adipokine visfatin are increased in pre-eclampsia. Fasshauer M; Waldeyer T; Seeger J; Schrey S; Ebert T; Kratzsch J; Lossner U; Bluher M; Stumvoll M; Faber R; Stepan H Clin Endocrinol (Oxf); 2008 Jul; 69(1):69-73. PubMed ID: 18034779 [TBL] [Abstract][Full Text] [Related]
9. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy. Alghasham AA; Barakat YA Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224 [TBL] [Abstract][Full Text] [Related]
10. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease. Valentini L; Wirth EK; Schweizer U; Hengstermann S; Schaper L; Koernicke T; Dietz E; Norman K; Buning C; Winklhofer-Roob BM; Lochs H; Ockenga J Nutrition; 2009 Feb; 25(2):172-81. PubMed ID: 18849144 [TBL] [Abstract][Full Text] [Related]